Status:
UNKNOWN
Venous Thrombus Investigation With Contrast Enhanced Ultrasound Imaging
Lead Sponsor:
University Hospital Freiburg
Conditions:
Deep Venous Thrombosis
Eligibility:
All Genders
18-80 years
Brief Summary
Background: During the repair process of deep venous thrombosis, capillary formation is seen from day 18 to day 25. Contrast agent investigation is well known to detect small vessels in arterial dise...
Detailed Description
1. Study set up and Study design It will be an open, non-randomized prospective clinical pilot study to assess the value of contrast agents in venous thrombus investigations. a. Hypothesis ...
Eligibility Criteria
Inclusion
- Age \> 18 and \< 80 years old
- Given written informed consent
- Patients with symptoms of deep venous thrombosis less than for 2 weeks Thrombus occluding without any reperfusion in color mode in the common femoral vein (CFV), the femoral vein (FV) or the popliteal vein (PV)
Exclusion
- Arterial occlusive disease
- Acute myocardial infarction, symptoms of coronary artery disease
- Pregnancy
- History of stroke or transient ischemic attack
- Arterial hypertension uncontrolled
- Allergy to contrast media
- Participation in another study
- Right heart insufficiency (clinical assessment with jugular vein filling in 45° sitting position)
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2008
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00677846
Start Date
April 1 2007
End Date
August 1 2008
Last Update
May 15 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Freiburg
Freiburg im Breisgau, Baden Würtemberg, Germany, 79110